Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabletes"

被引:11
作者
Kanauchi, Masao
Kanauchi, Kimiko
Inoue, Tomoko
Kimura, Kuniko
Saito, Yoshihiko
机构
[1] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6340813, Japan
[2] Sharp Co Ltd, Hlth Care Unit, Katsuragi, Japan
关键词
insulin resistance; metabolic syndrome; prediabetes; prehypertension; 75-g oral glucose tolerance test;
D O I
10.1515/CCLM.2007.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: There are few data on the impact of insulin resistance on the recently defined categories of prehypertension (PHT) and prediabetes (PDM). The aim of this study was to examine associations of surrogate markers of insulin resistance with PHT/PDM. Methods: Subjects included 554 individuals who underwent a 75-g oral glucose tolerance test (OGTT). They were classified into four groups using a severity score for high blood pressure and glucose tolerance. Insulin resistance was measured using the homeostasis model assessment of insulin resistance (HOMA-R) and three surrogate markers obtained from 75-g OGTT values (ISI-composite, Stumvoll index, and OGIS index). Results: HOMA-R increased significantly, but the other three surrogate indices decreased with increasing severity score. Of these markers, the OGIS index was mostly associated with prevalent PHT/PDM and the odds ratio for insulin resistance was 3.61 (95% Cl 1.68-7.76, p=0.001) for subjects with either PHT or PDM and 29.98 (12.81-70.18, p < 0.001) for subjects with both PHT and PDM. Conclusions: PHT and PDM frequently coexist in relatively lean Japanese subjects. Decreased insulin sensitivity may contribute to the underlying status of PHT/PDM. Among the surrogate markers of insulin resistance, the OGIS index is the most sensitive for assessment of PHT/PDM status.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 24 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc14-S081, 10.2337/dc11-S062, 10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc11-S011, 10.2337/dc12-s064, 10.2337/dc10-S011, 10.2337/dc13-S011]
[3]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   Prehypertension is associated with insulin resistance state and not with an initial renal function impairment -: A metabolic syndrome in active subjects in Spain (MESYAS) Registry substudy [J].
Cordero, A ;
Laclaustra, M ;
León, M ;
Grima, A ;
Casasnovas, JA ;
Luengo, E ;
del Rio, A ;
Ferreira, I ;
Alegria, E .
AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (02) :189-196
[6]   Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm [J].
Deedwania, PC ;
Fonseca, VA .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (09) :939-947
[7]  
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, Diabetes Care, V26, P5, DOI DOI 10.2337/DIACARE.26.2007.S5
[8]   INSULIN-STIMULATED GLUCOSE-UTILIZATION AND BORDERLINE HYPERTENSION IN YOUNG-ADULT BLACKS [J].
FALKNER, B ;
HULMAN, S ;
KUSHNER, H .
HYPERTENSION, 1993, 22 (01) :18-25
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   Glucose metabolism in patients with essential hypertension [J].
García-Puig, J ;
Ruilope, LM ;
Luque, M ;
Fernández, J ;
Ortega, R ;
Dal-Ré, R .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) :318-326